Literature DB >> 1100725

Structural and genetic basis of the in vivo immune response to TNP-LPS.

D M Jacobs.   

Abstract

TNP-lipopolysaccharide (TNP-LPS) is a potent T-independent antigen in vivo, inducing a TNP-PFC response in T-depleted animals. The structural integrity of the lipid A-KDO portion of the LPS carrier molecule appears to be required since the haptenated LPS from Salmonella minnesota Re595 is immunogenic whereas the haptenated derivative of base hydrolyzed LPS is not. The immune response is not associated with any of the common histocompatiblity types, but does depend on the ability of the host strain to respond to LPS. C3H/HeJ mice are not killed by low doses of LPS and give a poor PFC response to TNP-LPS. Lethality and immunogenicity are dominant responses in hybrids of C3H/HeJ and responder mice. The structural and genetic requirements for the response to TNP-LPS suggest an active role for the carrier in the immunogenicity of this T-independent antigen.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1100725

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  n-3 PUFAs enhance the frequency of murine B-cell subsets and restore the impairment of antibody production to a T-independent antigen in obesity.

Authors:  Heather Teague; Cassie J Fhaner; Mitchel Harris; David M Duriancik; Gavin E Reid; Saame Raza Shaikh
Journal:  J Lipid Res       Date:  2013-08-28       Impact factor: 5.922

2.  Hapten-specific B cell blockade of the immune response to a thymus-independent-1 antigen produced by concomitant administration of a thymus-independent-2 antigen.

Authors:  H Snippe; A J Van Houte; J K Inman; E F Lizzio; B Merchant
Journal:  Immunology       Date:  1984-05       Impact factor: 7.397

3.  Influence of dimethyl myleran on tolerance induction and immune function in major histocompatibility complex-haploidentical murine bone-marrow transplantation.

Authors:  E Ishii; N Gengozian; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.